iTeos Therapeutics (ITOS) Insider Trading & Ownership $7.25 +0.40 (+5.84%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock iTeos Therapeutics (NASDAQ:ITOS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$38,650.00Number OfInsiders Selling(Last 12 Months)0 Get ITOS Insider Trade Alerts Want to know when executives and insiders are buying or selling iTeos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ITOS Insider Buying and Selling by Quarter iTeos Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/19/2024Matthew GallCFOBuy5,000$7.73$38,650.00 (Data available from 1/1/2013 forward) ITOS Insider Trading Activity - Frequently Asked Questions Who is on iTeos Therapeutics's Insider Roster? The list of insiders at iTeos Therapeutics includes Aaron I Davis, Boxer Capital, Llc, David Hallal, and Matthew Gall. Learn more on insiders at ITOS. What percentage of iTeos Therapeutics stock is owned by insiders? 12.50% of iTeos Therapeutics stock is owned by insiders. Learn more on ITOS's insider holdings. Which iTeos Therapeutics insiders have been buying company stock? The following insider purchased ITOS shares in the last 24 months: Matthew Gall ($80,500.00). How much insider buying is happening at iTeos Therapeutics? Insiders have purchased a total of 10,000 ITOS shares in the last 24 months for a total of $80,500.00 bought. Which iTeos Therapeutics insiders have been selling company stock? The following insider sold ITOS shares in the last 24 months: Boxer Capital, Llc ($5,691,000.00). How much insider selling is happening at iTeos Therapeutics? Insiders have sold a total of 350,000 iTeos Therapeutics shares in the last 24 months for a total of $5,691,000.00 sold. iTeos Therapeutics Key ExecutivesDr. Michel Detheux Ph.D. (Age 57)President, CEO & Director Compensation: $1.04MMr. Matthew Gall (Age 47)Chief Financial Officer Compensation: $648k1 recent tradesMr. Matthew A. Call M.B.A. (Age 51)Chief Operating Officer Compensation: $706.21kDr. Yvonne McGrath Ph.D. (Age 50)Chief Scientific Officer Ms. Adi OsovskyExecutive Vice President of LegalMr. Philippe BrantegemExecutive Vice President of Human ResourcesDr. Joyson Joseph Karakunnel FACP (Age 53)M.D., M.Sc., Interim Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies IOVA Insider Trading WVE Insider Trading ETNB Insider Trading COLL Insider Trading MLYS Insider Trading NTLA Insider Trading SYRE Insider Trading ZYME Insider Trading RCUS Insider Trading NRIX Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold This page (NASDAQ:ITOS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iTeos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iTeos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ITOS Stock Free ITOS Stock Alerts